Clinical Trial Update: BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

View source ↗

Summary

This entry notes a clinical trial (NCT07511517) evaluating the BladMetrix urine test to monitor recurrence in non-muscle invasive bladder cancer, currently list…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer
• Urothelial Carcinoma of the Bladder

Snippet

Sponsor: Oslo University Hospital | Conditions: Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms | Status: ACTIVE_NOT_RECRUITING